Pumaprazole is a reversible proton pump antagonist.

Pantoprazole sodium is an inhibitor of proton pump that can suppress function of H+/K+ ATPase. It is used for the treatment of hyperacidity.

Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

AZD0865 inhibits gastric H+,K+-ATPase by K+-competitive binding.

Tenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM.

SCH 28080 is an inhibitor of H+, K+-ATPase with IC50 of 20 nM.

Pantoprazole sodium is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

Esomeprazole Magnesium Trihydrate can inhibit the H+/K+ ATPase and reduce acid secretion of gastric parietal cells.

Rabeprazole sodium is an inhibitor of proton pump with antiulcer activities.

Lansoprazole is an inhibitor of proton-pump. It can reduce the gastric acid production of stomach.

Omeprazole sulfide is an inhibitor of proton pump, it is the metabolite of omeprazole.

Esomeprazole sodium, the sodium salt of esomeprazole which has the effect of reducing gastric acid secretion.

Omeprazole is an inhibitor of proton pump with IC50 of 1.1 μM which can be used to treat dyspepsia.

Ilaprazole inhibited TOPK activities with high affinity and selectivity.

(R)-Lansoprazole, the dextrorotatory enantiomer of lansoprazole, can irreversibly inactivate the H+/K+-stimulated ATPase pump.

Esomeprazole magnesium is a proton pump inhibitor for the treatment of gastric acid secretion.